1,080 reports of this reaction
1.7% of all DOXORUBICIN HYDROCHLORIDE reports
#13 most reported adverse reaction
HAIR COLOUR CHANGES is the #13 most commonly reported adverse reaction for DOXORUBICIN HYDROCHLORIDE, manufactured by Baxter Healthcare Company. There are 1,080 FDA adverse event reports linking DOXORUBICIN HYDROCHLORIDE to HAIR COLOUR CHANGES. This represents approximately 1.7% of all 64,420 adverse event reports for this drug.
Patients taking DOXORUBICIN HYDROCHLORIDE who experience hair colour changes should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HAIR COLOUR CHANGES is a less commonly reported adverse event for DOXORUBICIN HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to hair colour changes, the following adverse reactions have been reported for DOXORUBICIN HYDROCHLORIDE:
The following drugs have also been linked to hair colour changes in FDA adverse event reports:
HAIR COLOUR CHANGES has been reported as an adverse event in 1,080 FDA reports for DOXORUBICIN HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HAIR COLOUR CHANGES accounts for approximately 1.7% of all adverse event reports for DOXORUBICIN HYDROCHLORIDE, making it a notable side effect.
If you experience hair colour changes while taking DOXORUBICIN HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.